Elanco Animal Health Stock Buy Hold or Sell Recommendation
| ELAN Stock | USD 11.11 0.09 0.82% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Elanco Animal Health is 'Strong Sell'. The recommendation algorithm takes into account all of Elanco Animal's available fundamental, technical, and predictive indicators you will find on this site.
Check out Elanco Animal Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Elanco and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Elanco |
Execute Elanco Animal Buy or Sell Advice
The Elanco recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Elanco Animal Health. Macroaxis does not own or have any residual interests in Elanco Animal Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Elanco Animal's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Elanco Animal Trading Alerts and Improvement Suggestions
| Elanco Animal Health generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 4.42 B. Net Loss for the year was (1.23 B) with profit before overhead, payroll, taxes, and interest of 2.44 B. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Elanco Animal Health Inc Launches Pet Protect A New Line of Veterinarian-Formulated Pet ... |
Elanco Animal Returns Distribution Density
The distribution of Elanco Animal's historical returns is an attempt to chart the uncertainty of Elanco Animal's future price movements. The chart of the probability distribution of Elanco Animal daily returns describes the distribution of returns around its average expected value. We use Elanco Animal Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Elanco Animal returns is essential to provide solid investment advice for Elanco Animal.
| Mean Return | -0.33 | Value At Risk | -3.79 | Potential Upside | 2.46 | Standard Deviation | 2.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Elanco Animal historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Elanco Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Elanco Animal, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Elanco Animal Health back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Magnetar Financial Llc | 2024-12-31 | 12 M | State Street Corp | 2024-12-31 | 10.4 M | Geode Capital Management, Llc | 2024-12-31 | 8.2 M | Citadel Advisors Llc | 2024-09-30 | 7.5 M | Manufacturers Life Insurance Co | 2024-12-31 | 6.9 M | Brandes Investment Partners & Co | 2024-12-31 | 5.7 M | Charles Schwab Investment Management Inc | 2024-12-31 | 4.7 M | Prudential Financial Inc | 2024-12-31 | 4.2 M | Ubs Group Ag | 2024-12-31 | 4.2 M | Dodge & Cox | 2024-12-31 | 83.2 M | Primecap Management Company | 2024-12-31 | 51.2 M |
Elanco Animal Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (94.7M) | 27M | (269M) | (160M) | (144M) | (136.8M) | |
| Change In Cash | 160.3M | 132M | (293M) | 7M | 6.3M | 6.0M | |
| Net Borrowings | (121.1M) | 3.8B | 241M | (518M) | (466.2M) | (442.9M) | |
| Free Cash Flow | (351.9M) | 286M | 268M | 117M | 134.6M | 88.7M | |
| Depreciation | 516.9M | 716M | 682M | 694M | 798.1M | 492.4M | |
| Other Non Cash Items | (86.4M) | 414M | 308M | 1.1B | 1.3B | 1.4B | |
| Capital Expenditures | 310.9M | 197M | 184M | 154M | 177.1M | 181.7M | |
| Net Income | (560.1M) | (472M) | (78M) | (1.2B) | (1.1B) | (1.1B) | |
| End Period Cash Flow | 505.4M | 638M | 345M | 352M | 404.8M | 477.4M | |
| Change To Netincome | 36.8M | (278.7M) | 326M | 22M | 25.3M | 47.7M | |
| Investments | 32.7M | (530M) | (179M) | (210M) | (241.5M) | (253.6M) |
Elanco Animal Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Elanco Animal or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Elanco Animal's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Elanco stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | -0.02 | |
σ | Overall volatility | 2.10 | |
Ir | Information ratio | -0.17 |
Elanco Animal Volatility Alert
Elanco Animal Health exhibits very low volatility with skewness of -0.72 and kurtosis of 1.62. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Elanco Animal's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Elanco Animal's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Elanco Animal Fundamentals Vs Peers
Comparing Elanco Animal's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elanco Animal's direct or indirect competition across all of the common fundamentals between Elanco Animal and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elanco Animal or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elanco Animal's fundamental indicators could also be used in its relative valuation, which is a method of valuing Elanco Animal by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elanco Animal to competition |
| Fundamentals | Elanco Animal | Peer Average |
| Return On Equity | 0.0324 | -0.31 |
| Return On Asset | 0.0118 | -0.14 |
| Profit Margin | 0.05 % | (1.27) % |
| Operating Margin | (0) % | (5.51) % |
| Current Valuation | 9.36 B | 16.62 B |
| Shares Outstanding | 494.35 M | 571.82 M |
| Shares Owned By Insiders | 0.97 % | 10.09 % |
| Shares Owned By Institutions | 99.12 % | 39.21 % |
| Number Of Shares Shorted | 16.59 M | 4.71 M |
| Price To Earning | 241.75 X | 28.72 X |
| Price To Book | 0.84 X | 9.51 X |
| Price To Sales | 1.19 X | 11.42 X |
| Revenue | 4.42 B | 9.43 B |
| Gross Profit | 2.44 B | 27.38 B |
| EBITDA | (224 M) | 3.9 B |
| Net Income | (1.23 B) | 570.98 M |
| Cash And Equivalents | 463 M | 2.7 B |
| Cash Per Share | 0.98 X | 5.01 X |
| Total Debt | 5.77 B | 5.32 B |
| Debt To Equity | 0.87 % | 48.70 % |
| Current Ratio | 1.96 X | 2.16 X |
| Book Value Per Share | 13.20 X | 1.93 K |
| Cash Flow From Operations | 271 M | 971.22 M |
| Short Ratio | 3.63 X | 4.00 X |
| Earnings Per Share | 0.41 X | 3.12 X |
| Price To Earnings To Growth | 1.84 X | 4.89 X |
| Target Price | 16.67 | |
| Number Of Employees | 9.3 K | 18.84 K |
| Beta | 1.42 | -0.15 |
| Market Capitalization | 5.29 B | 19.03 B |
| Total Asset | 14.36 B | 29.47 B |
| Retained Earnings | (2.29 B) | 9.33 B |
| Working Capital | 2.17 B | 1.48 B |
Note: Disposition of 195840 shares by Jeffrey Simmons of Elanco Animal at 11.24 subject to Rule 16b-3 [view details]
Elanco Animal Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Elanco . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Elanco Animal Buy or Sell Advice
When is the right time to buy or sell Elanco Animal Health? Buying financial instruments such as Elanco Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Elanco Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Manufacturing Thematic Idea Now
Manufacturing
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Elanco Animal Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.41 | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.